Showing Results For "pharmaceuticals"
Indian-origin scientist finds way to develop better drugs

Indian-origin scientist finds way to develop better drugs

26 Aug 2014

New York: An Indian-origin researcher at Michigan Technological University has deciphered how Glycoconjugates-biomolecules that hold sugars in the body like scaffolds for reacting with other molecules, can lead to new and better drugs.

Indian-origin scientist,   drugs,   scaffolds,   drug,   pharmaceuticals,   ,  
Eight Chinese quarantined as panic grips Ebola-hit West Africa

Eight Chinese quarantined as panic grips Ebola-hit West Africa

12 Aug 2014

Freetown: Eight Chinese medical workers who treated Ebola patients have been quarantined in Sierra Leone, as health experts grapple with ethical questions over the use of experimental drugs to combat the killer virus.

Ebola Epidemic,   China,   ZMapp,   Ebola infections,   Mapp Pharmaceuticals,   Ebola vaccine,  
Supreme Court asks Andhra HC to decide on Ranbaxy-Sun Pharma merger within two days

Supreme Court asks Andhra HC to decide on Ranbaxy-Sun Pharma merger within two days

21 May 2014

New Delhi: The Supreme Court on Wednesday asked the Andhra Pradesh High Court to take a decision within two days on a plea challenging merger of Sun Pharmaceutical with Ranbaxy.

Ranbaxy,   Sun Pharmaceuticals,   Andhra Pradesh high court,   Ranbaxy-Sun Pharma merger,   Supreme Court,   ,  
Ranbaxy Q4 net loss declines sharply to Rs 158.48 crore

Ranbaxy Q4 net loss declines sharply to Rs 158.48 crore

05 Feb 2014

New Delhi: Pharma major Ranbaxy Laboratories on Wednesday reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31, 2013.

Ranbaxy Q4 net loss,   Ranbaxy Laboratories,   Ranbaxy net loss,   Ranbaxy pharmaceuticals,  
US drug probes: Johnson & Johnson to pay USD 2.2 billion

US drug probes: Johnson & Johnson to pay USD 2.2 billion

05 Nov 2013

Washington: In one of the largest health care fraud settlements in US history, Johnson & Johnson will pay USD 2.2 billion to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses, US Attorney General Eric Holder said on Monday.

health care fraud,   US drug probes,   Johnson & Johnson,   criminal investigations,   pharmaceuticals ,  
Microsoft in talks with ValueAct over board seat: Sources

Microsoft in talks with ValueAct over board seat: Sources

22 Jul 2013

New York/Seattle: Members of Microsoft Corp's board have held talks with ValueAct Capital Management LP in recent days over the activist shareholder's demands to secure a seat on the company's board, two sources close to the matter said.

ValueAct,   Microsoft,   Surface tablet,  Motorola Solutions Inc,   Valeant Pharmaceuticals International Inc ,  
Sun Pharma looking for larger acquisitions in key markets

Sun Pharma looking for larger acquisitions in key markets

09 Nov 2012

A day after it announced the USD 230 million deal to buy a US-based company, Sun Pharmaceutical Industries on Friday said it is looking forward to larger acquisitions as a part of its expansion plans.

Sun Pharma,   Pharma industry,   acquisitions,   BSE,   DUSA Pharmaceuticals,  
Life saving drugs prices to come down by upto 80 percent

Life saving drugs prices to come down by upto 80 percent

17 May 2013

Prices of 348 medicines, including life saving drugs, will be cheaper soon by up to 80 percent as the new Drug Price Control Order has come into effect.

Life saving drugs,   drugs to be cheaper,   National Pharmaceutical Pricing Policy,   National Pharmaceuticals Pricing Authority,   Drug Price Control Order,   medicines to be cheaper,  
Lupin gets USFDA nod for generic Avapro tablets

Lupin gets USFDA nod for generic Avapro tablets

17 Oct 2012

Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.

Lupin Pharmaceuticals,   USFDA,   USFDA nod Avapro pills,   generic drugs,  
Dr Reddy's Labs to overtake OctoPlus NV for Euro 27.4 million

Dr Reddy's Labs to overtake OctoPlus NV for Euro 27.4 million

22 Oct 2012

Drug maker Dr Reddy's Laboratories on Monday said it has decided to acquire Netherlands-based OctoPlus NV, a speciality pharmaceutical company, for about 27.4 million euros (about Rs 193 crore).

Dr Reddy’s Labs,   OctoPlus,   acquire,   Netherlands-pharmaceuticals,   GV Prasad,   drug delivery,   DRL,  

1 2